NS · Healthcare

Sotac Pharmaceuticals Ltd (SOTAC)

Pharmaceuticals & Biotechnology

Sotac Pharmaceuticals Ltd (SOTAC) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $1.17B, P/E ratio is 24.94, dividend yield is 0.09%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for SOTAC

Market cap

$1.17B

P/E ratio

24.94

Dividend yield

0.09%

Sotac Pharmaceuticals Ltd (SOTAC) — FAQ

What is Sotac Pharmaceuticals Ltd's market cap?

Sotac Pharmaceuticals Ltd (SOTAC) has a reported market cap of $1.17B (data as of 2026-07-10).

What is SOTAC's P/E ratio?

The price-to-earnings (P/E) ratio for Sotac Pharmaceuticals Ltd (SOTAC) is 24.94 (data as of 2026-07-10).

Does Sotac Pharmaceuticals Ltd pay a dividend?

Sotac Pharmaceuticals Ltd (SOTAC) shows a reported dividend yield of 0.09%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).

What sector is Sotac Pharmaceuticals Ltd in?

Sotac Pharmaceuticals Ltd (SOTAC) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is SOTAC listed on?

SOTAC is listed on NS.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)